AVENUE THERAPEUTICS, INC. (ATXI) › Operating Cash FlowAVENUE THERAPEUTICS, INC. (ATXI) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2016: -$1.63M2017: -$6.80M2018: -$18.22M2019: -$26.26M2020: -$4.61M2021: -$3.75M2022: -$7.60M2023: -$9.45M2024: -$9.03M2025: -$1.83M-$1.83M2016Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$1.83M+79.7%2024-$9.03M+4.5%2023-$9.45M-24.4%2022-$7.60M-102.6%2021-$3.75M+18.7%2020-$4.61M+82.4%2019-$26.26M-44.2%2018-$18.22M-167.8%2017-$6.80M-316.8%2016-$1.63M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share